S66 — Star Combo Pharma Income Statement
0.000.00%
Last trade - 00:00
- AU$16.21m
- AU$11.32m
- AU$24.99m
- 88
- 84
- 69
- 92
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | AAS | AAS | AAS | AAS | AAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21.6 | 39.1 | 27.1 | 23.9 | 25 |
Cost of Revenue | |||||
Gross Profit | 3.92 | 4.06 | 3.54 | 5.34 | 5.13 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 24 | 40.8 | 35.3 | 24.9 | 28.2 |
Operating Profit | -2.45 | -1.71 | -8.21 | -0.957 | -3.22 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -2.34 | -0.906 | -7.46 | -1.08 | -3.45 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.73 | -0.349 | -7.88 | -0.696 | -4 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.73 | -0.349 | -7.88 | -0.696 | -4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.73 | -0.349 | -7.88 | -0.696 | -4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.021 | -0.001 | -0.028 | 0.002 | -0.008 |